Fortress Biotech Stock Price on December 3, 2024
| FBIO Stock | USD 2.06 0.06 2.83% |
Below is the normalized historical share price chart for Fortress Biotech extending back to November 17, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Fortress Biotech stands at 2.06, as last reported on the 11th of December 2024, with the highest price reaching 2.17 and the lowest price hitting 2.04 during the day.
If you're considering investing in Fortress Stock, it is important to understand the factors that can impact its price. Fortress Biotech appears to be somewhat reliable, given 3 months investment horizon. Fortress Biotech secures Sharpe Ratio (or Efficiency) of 0.0612, which denotes the company had a 0.0612% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Fortress Biotech, which you can use to evaluate the volatility of the firm. Please utilize Fortress Biotech's Coefficient Of Variation of 1302.49, mean deviation of 3.75, and Downside Deviation of 4.94 to check if our risk estimates are consistent with your expectations.
At this time, Fortress Biotech's Common Stock Total Equity is very stable compared to the past year. As of the 11th of December 2024, Liabilities And Stockholders Equity is likely to grow to about 198.4 M, while Common Stock Shares Outstanding is likely to drop about 4.5 M. . As of the 11th of December 2024, Price Earnings To Growth Ratio is likely to grow to 0.01, while Price To Sales Ratio is likely to drop 0.27. Fortress Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of November 2011 | 200 Day MA 1.857 | 50 Day MA 1.7232 | Beta 1.746 |
Fortress |
Sharpe Ratio = 0.0612
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | FBIO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.27 actual daily | 46 54% of assets are more volatile |
Expected Return
| 0.32 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Fortress Biotech is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fortress Biotech by adding it to a well-diversified portfolio.
Price Book 2.675 | Enterprise Value Ebitda (0.29) | Price Sales 0.7517 | Shares Float 16.1 M | Wall Street Target Price 14 |
Related Headline
Pieris Pharmaceuticals Headline on 3rd of December 2024
Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chie... by finance.yahoo.com
BASEL, Switzerland 3rd December 2024 - Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized neoantigen cancer immunotherapies, announces the appointment of Eckhard Niemeier as its Chief Business Officer . With over 20 years of experience in life sciences corporate development and strategy, Eckhard will work closely with the leadership team and play a key role in shaping Nouscoms growth. Dr. Marina Udier, CEO of Nouscom, commented on the appointment
Fortress Biotech Valuation on December 3, 2024
It is possible to determine the worth of Fortress Biotech on a given historical date. On December 3, 2024 Fortress was worth 2.3 at the beginning of the trading date compared to the closed value of 2.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Fortress Biotech stock. Still, in general, we apply an absolute valuation method to find Fortress Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fortress Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Fortress Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 2.17 | 2.34 | 2.08 | 2.30 | 2,089,618 | |
12/03/2024 | 2.30 | 2.32 | 2.15 | 2.19 | 634,042 |
| 2.16 | 2.23 | 2.10 | 2.18 | 634,997 |
| Backtest Fortress Biotech | | | Fortress Biotech History | | | Fortress Biotech Valuation | Previous | Next |
Fortress Biotech Trading Date Momentum on December 3, 2024
| On December 04 2024 Fortress Biotech was traded for 2.18 at the closing time. The top price for the day was 2.23 and the lowest listed price was 2.10 . The trading volume for the day was 635 K. The trading history from December 4, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.46% . The overall trading delta against the current closing price is 3.20% . |
Fortress Biotech Fundamentals Correlations and Trends
By evaluating Fortress Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Fortress Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Fortress financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Fortress Biotech Stock history
Fortress Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fortress is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fortress Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fortress Biotech stock prices may prove useful in developing a viable investing in Fortress Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 8.1 M | 4.5 M | |
| Net Loss | -58.2 M | -61.1 M |
Fortress Biotech Stock Technical Analysis
Fortress Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Fortress Biotech Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Fortress Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Fortress Biotech December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Fortress Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fortress Biotech shares will generate the highest return on investment. By undertsting and applying Fortress Biotech stock market strength indicators, traders can identify Fortress Biotech entry and exit signals to maximize returns
Fortress Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Fortress Biotech's price direction in advance. Along with the technical and fundamental analysis of Fortress Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Fortress to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0641 | |||
| Jensen Alpha | 0.2274 | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.0555 | |||
| Treynor Ratio | 0.2754 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.73) | Revenue Per Share 6.15 | Quarterly Revenue Growth (0.14) | Return On Assets (0.36) | Return On Equity (17.40) |
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.